Rabies is still responsible for approximately 60,000 human deaths per year mostly in Asia and Africa and affects especially underserved people. Prophylactic measures have significantly improved. They are now composed of the vaccine allied to purified human or equine rabies immunoglobulins. However, these immunoglobulins are expensive and not easy to reach in developing settings. Researchers have visualized one of the most potent and most broadly neutralizing human monoclonal antibody in interaction with the rabies glycoprotein.
from Latest Science News -- ScienceDaily https://ift.tt/2uIaX2u
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment